Navigation Links
KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director
Date:2/26/2008

x type II," appearing in the Journal of Osteopathic Physicians & Surgeons of California.

Among his numerous accomplishments, Dr. Chesky is a past president of the Osteopathic Physicians and Surgeons of California. He has held nine teaching positions, including Clinical Associate Professor, Obstetrics and Gynecology at Ohio University; Chairman of the Department and full professor of Obstetrics and Gynecology at the College of Osteopathic Medicine of the Pacific of Western University of Health Sciences; and held an academic appointment in Obstetrics and Gynecology at the University of California at Irvine.

Dr. Chesky received his Doctor of Osteopathic Medicine degree from Midwestern University/ Chicago College of Osteopathic Medicine; his specialty is Obstetrical and Gynecological Surgery. He is licensed to practice medicine in multiple states, including Ohio.

He received his Juris Doctorate degree from the Ohio Northern University College of Law. His Bachelor of Science degree is from Roosevelt University.

Professional affiliations include, fellow of the American College of Legal Medicine, distinguished fellow of the American College of Osteopathic Obstetricians and Gynecologists, the American Osteopathic Association, and the Association of Trial Lawyers of America.

About KePRO

KePRO and its family of companies offer utilization, case, and disease management solutions to more than four million lives in the United States in both the public and private sectors. By transforming data into action, KePRO's evidence-based approach to patient-centric care optimizes individual health outcomes while delivering financial results.

Headquartered in Pennsylvania, KePRO also has offices in Florida, Kentucky, Maryland, Ohio, Tennessee, and Virginia. KePRO is URAC health utilization management and case management accredited. For more information about KePRO, visit http://www.kepro.org.
'/>"/>

SOURCE KePRO
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sharon McCudden Named KePRO Director of Business Process Improvement & Compliance
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. Mediware Names Thomas K. Mann Chief Executive Officer
4. Cleveland-based Health Care Tech Company Within3 Names New CEO
5. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
6. Patient Safety Authority Board of Directors Names Infection Advisory Panel
7. Hooper Holmes Names Chris Behling President of Health & Wellness Division
8. MDMA Names New Director of Federal Affairs
9. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... LiveSchool ” was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... students with good behavior. , Positive re-enforcement is more ... And the good people at LiveSchool have taken note ...
(Date:5/4/2015)... May 04, 2015 The American Telemedicine ... state policy reports which identify gaps in coverage and ... ATA issued the State Telemedicine Gaps Reports last September, ... their laws and regulations impact healthcare delivery in their ... result of state actions across the nation, ATA reevaluated ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 In May ... Smalley took his own life. In the wake of this ... the Silent, an organization that exposes the grim reality of ... also a platform for Kirk and Laura to share their ... their tragedy from happening to another family — a mission ...
(Date:5/4/2015)... Now in its seventh year, the IPC ... made outstanding contributions to the company, to their facilities ... and post-acute care settings. The five award categories are: ... Year, Advanced Practice Clinician of the Year, Newcomer Provider ... Recipients are selected by IPC’s senior management team. , ...
(Date:5/4/2015)... May 04, 2015 EyeCRO LLC and ... to facilitate development of NM108, a first-in-class small molecule ... to blindness, including Diabetic Retinopathy. The collaboration grants ... by EyeCRO, which can deliver drugs to the front ... , Under the terms of the agreement, EyeCRO ...
Breaking Medicine News(10 mins):Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3
... ROCKFORD, Mich., Aug. 31 Pediatric Wildlife Care Tables, ... answer to an age-old problem for doctors, nurses and healthcare ... , , Constantly in need of ... long relied on bulky rolling computer tables to temporarily stow ...
... along with alcohol use, survey shows , MONDAY, Aug. ... are often exercisers. , According to a new University ... the American Journal of Health Promotion , the ... exercise. , "Alcohol users not only exercised more ...
... , Politics and Possibilities of Health ... WASHINGTON, Aug. 31 URAC ... that several key policy makers and insurance leaders will lead a discussion, ... Care Landscape," at URAC,s 10th Annual Quality Summit and Exhibit ...
... , , , ... (Nasdaq: PPHM ), today announced that noted cancer researcher Bruce ... the design of clinical trials for the bavituximab cancer program. Dr. ... Center, chief of hematology and oncology at MGH and a professor of ...
... 31 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading,pharmaceutical ... that,it received the Highest Growth Potential Award from ... announced at the 10th anniversary celebration of,"Focus on ... Vice President,for Process Chemistry and GMP Operations, attended ...
... , , , ... medical technology systems integrator transforming critical care, announced that former Veterans ... Board of Advisors. , , Secretary Peake retired ... and commander in several medical posts culminating in his appointment as ...
Cached Medicine News:Health News:Foldaway Pediatric Point of Care Table Provides Efficient Work Surface Without Compromising Space 2Health News:Drinkers May Exercise More Than Teetotalers 2Health News:Policy Makers Discuss Health Care Reform at URAC Quality Summit 2Health News:Policy Makers Discuss Health Care Reform at URAC Quality Summit 3Health News:Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 2Health News:Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 3Health News:Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs 4Health News:Sundia Receives the Highest Growth Potential Award from Zhangjiang 2Health News:Former Veterans Affairs Secretary Joins Integrated Medical Systems' Advisory Board 2Health News:Former Veterans Affairs Secretary Joins Integrated Medical Systems' Advisory Board 3
(Date:5/4/2015)... 2015 PharmaEngine, Inc. (TWO:4162) today announced ... MACK ) with its sublicensing partner, Baxter ... that Baxter has submitted a marketing authorization application ... MM-398 (irinotecan liposome injection), also known as "nal-IRI," ... who have been previously treated with gemcitabine-based therapy. ...
(Date:5/4/2015)... 2015  Oncobiologics, Inc., a biotherapeutics company focused ... has completed the construction of its GMP commercial ... Cranbury, New Jersey . ... designed to utilize multiple technologies that enable rapid ... the use of the latest single-use technologies, the ...
(Date:5/4/2015)... , May 4, 2015   HeartWare International, Inc ... invasive, miniaturized circulatory support technologies that are revolutionizing the treatment ... Doug Godshall , is scheduled to present at the ... Las Vegas on Thursday, May 14, ... The live webcast of the Company,s presentation at the conference ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
... I clinical trial in healthy subjects- Study aims ... new vaccine candidate- Initial results expected in Q4 ... by PATHVIENNA, April 7 Intercell AG (VSE: ... trial with the company,s vaccine candidate IC47 to ...
... Glycotex, Inc. today announced the completion of a scheduled ... effect of investigational GLYC-101 gel on complete wound closure ... dioxide laser skin resurfacing on the lower eyelid area.The ... study. The comparison of each active arm to placebo ...
Cached Medicine Technology:Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine 2Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine 3Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 2Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 3
... Wampole Laboratories offers a comprehensive line ... for serum and urine in convenient one-step ... offers 2 testing options. Clearview Easy HCG ... a convenient stick format. Clearview HCG ...
... line of pregnancy tests including rapid membrane ... one-step stick and cassette formats. The Clearview ... HCG is a 25 mIU urine test ... HCG II provides 25mIU sensitivity for urine ...
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
Rapid turn-around time, results in less than 4 hours...
Medicine Products: